Free tool
Drug Trial Radar: Psychiatry
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Active, not recruiting, industry sponsors, Psychiatry, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed482
4 trials
Showing 1 to 4, recently updated first.
- iSTEP-N 101b: Pharmacokinetics and Safety Study of iSTEP-N Implant vs Monthly Vivitrol in Healthy VolunteersActive, not recruiting
Akyso Therapeutics, LLCIndustry
NCT07064564 · 21 participants · Start Jul 25, 2026 · Primary completion Oct 1, 2029
Drug: Naltrexone implant, 9.6 grams; Extended-release naltrexone injection, 380 mg · For: Opioid Use Disorder
Sites: Millcreek, Utah
- Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy VolunteersActive, not recruiting
Vigonvita Life SciencesIndustry
NCT06105151 · 82 participants (planned) · Start Oct 27, 2023 · Primary completion Oct 2026
Drug: VV119(SAD); VV119 Placebo(SAD) and 1 more · For: Schizophrenia
Sites: Beijing, China
- A Food Effect Study of LY03020 in Healthy SubjectsActive, not recruiting
Luye Pharma Group Ltd.Industry
NCT07292233 · 16 participants · Start Jul 30, 2025 · Primary completion Aug 27, 2025
Drug: LY03020 · For: Schizophrenia; Alzheimer's Disease Psychosis
Sites: Beijing, China
- ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With DepressionActive, not recruiting
Eleusis TherapeuticsIndustry
NCT05434156 · 84 participants (planned) · Start Oct 27, 2022 · Primary completion Dec 2025
Drug: ELE-101; ELE-101 Placebo · For: Healthy Volunteers; Major Depressive Disorder; Depression
Sites: Liverpool, United Kingdom; Manchester, United Kingdom
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.